Go Pro
NASDAQ:MMSI

Merit Medical Systems (MMSI) Stock Price, News & Analysis

Merit Medical Systems logo
$90.76 +0.26 (+0.29%)
Closing price 08/14/2026 04:00 PM Eastern
Extended Trading
$90.70 -0.06 (-0.07%)
As of 08/14/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Merit Medical Systems Stock (NASDAQ:MMSI)

Advanced

Key Stats

Today's Range
$89.99
$90.98
50-Day Range
$65.24
$91.20
52-Week Range
$59.74
$94.75
Volume
729,848 shs
Average Volume
1.17 million shs
Market Capitalization
$5.42 billion
P/E Ratio
37.50
Dividend Yield
N/A
Price Target
$100.00
Consensus Rating
Moderate Buy

Company Overview

Merit Medical Systems, Inc. is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach. Headquartered in South Jordan, Utah, the company operates manufacturing and distribution facilities in North America, Europe and Asia. Merit’s products are sold in over 90 countries worldwide, with regional sales offices in Europe, Latin America and the Asia‐Pacific region to support local clinical training and customer service.

Under the leadership of founder and CEO Fred Lampropoulos, Merit Medical Systems has maintained a focus on innovation, quality and customer education. The company invests in research and development to evolve its product pipeline and partners with healthcare professionals to improve procedural outcomes. Merit’s commitment to minimally invasive care and patient safety has positioned it as a key supplier to hospitals and health systems seeking advanced device solutions for complex diagnostic and therapeutic procedures.

AI Generated. May Contain Errors.

Merit Medical Systems Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

MMSI MarketRank™: 

Merit Medical Systems scored higher than 70% of companies evaluated by MarketBeat, and ranked 238th out of 912 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Merit Medical Systems has received a consensus rating of Moderate Buy. The company's average rating score is 2.67, and is based on no strong buy ratings, 8 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Merit Medical Systems has a consensus price target of $100.00, representing about 10.2% upside from its current price of $90.76.

  • Amount of Analyst Coverage

    Merit Medical Systems has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Merit Medical Systems' stock forecast and price target.
  • Earnings Growth

    Earnings for Merit Medical Systems are expected to grow by 8.40% in the coming year, from $3.81 to $4.13 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Merit Medical Systems is 37.50, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 45.63.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Merit Medical Systems is 37.50, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 271.26.

  • Price to Earnings Growth Ratio

    Merit Medical Systems has a PEG Ratio of 2.28. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Merit Medical Systems has a P/B Ratio of 3.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Merit Medical Systems' valuation and earnings.
  • Percentage of Shares Shorted

    6.30% of the float of Merit Medical Systems has been sold short.
  • Short Interest Ratio / Days to Cover

    Merit Medical Systems has a short interest ratio ("days to cover") of 3.74, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Merit Medical Systems has recently increased by 8.68%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Merit Medical Systems does not currently pay a dividend.

  • Dividend Growth

    Merit Medical Systems does not have a long track record of dividend growth.

  • News Sentiment

    Merit Medical Systems has a news sentiment score of 1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.65 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 15 news articles for Merit Medical Systems this week, compared to 5 articles on an average week.
  • Search Interest

    4 people have searched for MMSI on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Merit Medical Systems insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    0.70% of the stock of Merit Medical Systems is held by insiders.

  • Percentage Held by Institutions

    99.66% of the stock of Merit Medical Systems is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Merit Medical Systems' insider trading history.
Receive MMSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Merit Medical Systems and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MMSI Stock News Headlines

BTIG Research Reaffirms Buy Rating for Merit Medical Systems (NASDAQ:MMSI)
Why acquisitions are reshaping the gold mining sector right now
Gold major acquisitions have repriced junior miners overnight, with past deals delivering gains from 40% to 1,228.6% for shareholders of companies like G2 Goldfields, Loncor Gold, and Rupert Resources. Analyst Garrett Goggin, CFA, CMT, tracks which small miners hold the grade, cash flow, and assets that attract buyout interest from major producers. One quarter of his tracked portfolio has already been acquired as the gold bull market's M and A phase accelerates.tc pixel
Merit Medical (MMSI) Q2 2026 Earnings Call Transcript
See More Headlines

MMSI Stock Analysis - Frequently Asked Questions

Merit Medical Systems' stock was trading at $88.14 at the beginning of 2026. Since then, MMSI stock has increased by 3.0% and is now trading at $90.76.

Merit Medical Systems, Inc. (NASDAQ:MMSI) issued its earnings results on Thursday, July, 30th. The medical instruments supplier reported $1.19 earnings per share for the quarter, topping the consensus estimate of $0.96 by $0.23. The company's revenue was up 9.5% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Merit Medical Systems: Fibrovein Holdings Limited, Brightwater Medical Inc., Vascular Insights LLC, Cianna Medical Inc., DFINE Inc., BioSphere Medical SA, Alveolus Inc., and others.

Merit Medical Systems' top institutional investors include William Blair Investment Management LLC (1.91%), The Manufacturers Life Insurance Company (0.81%), Bank of New York Mellon Corp (0.69%) and J. Goldman & Co LP (0.41%). Insiders that own company stock include Fred P Lampropoulos, Joseph Wright, F Ann Millner, Raul Jr Parra, Thomas James Gunderson, Neil Peterson, Lynne N Ward, David Floyd, Stephen C Evans and Brian G Lloyd.
View institutional ownership trends
.

Shares of MMSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Merit Medical Systems investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), DiamondRock Hospitality (DRH), The RMR Group (RMR), Voyager Therapeutics (VYGR) and AUO (AUOTY).

Company Calendar

Last Earnings
7/30/2026
Today
8/16/2026
Next Earnings (Estimated)
10/29/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Supplies
Current Symbol
NASDAQ:MMSI
CIK
856982
Employees
7,500
Year Founded
1987

Price Target and Rating

High Price Target
$114.00
Low Price Target
$83.00
Potential Upside/Downside
+10.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
12 Analysts

Profitability

EPS (Trailing Twelve Months)
$2.42
Trailing P/E Ratio
37.50
Forward P/E Ratio
23.82
P/E Growth
2.28
Net Income
$128.49 million
Net Margins
9.22%
Pretax Margin
12.32%
Return on Equity
13.75%
Return on Assets
8.10%

Debt

Debt-to-Equity Ratio
0.44
Current Ratio
4.20
Quick Ratio
2.79

Sales & Book Value

Annual Sales
$1.52 billion
Price / Sales
3.57
Cash Flow
$5.88 per share
Price / Cash Flow
15.44
Book Value
$28.13 per share
Price / Book
3.23

Miscellaneous

Outstanding Shares
59,710,000
Free Float
59,292,000
Market Cap
$5.42 billion
Optionable
Optionable
Beta
0.49

Social Links

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

This page (NASDAQ:MMSI) was last updated on 8/16/2026 by MarketBeat.com Staff.
From Our Partners